Cart
sales@molnova.com
VCH-916
CAS No. 1200133-34-1
VCH-916( —— )
Catalog No. M23370 CAS No. 1200133-34-1
VCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 98 | In Stock |
|
| 5MG | 140 | In Stock |
|
| 10MG | 185 | In Stock |
|
| 25MG | 341 | In Stock |
|
| 50MG | 550 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVCH-916
-
NoteResearch use only, not for human use.
-
Brief DescriptionVCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase.
-
DescriptionVCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHCV
-
RecptorNS5B polymerase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1200133-34-1
-
Formula Weight497.73
-
Molecular FormulaC26H36KNO4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:36 mg/mL (72.33 mM)
-
SMILESO=C(C1=C(N([C@H]2CC[C@H](OC)CC2)C([C@H]3CC[C@H](C)CC3)=O)C=C(C4=CCCCC4)S1)O[K]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Abdelrahman S. Mayhoub. Hepatitis C RNA-dependent RNA polymerase inhibitors: A review of structure-activity and resistance relationships; different scaffolds and mutations. Bioorganic & Medicinal Chemistry. 2012, 20 (10): 3150-3161.
molnova catalog
related products
-
Radalbuvir
Radalbuvir (GS-9669) is a highly optimized thumb site II nonnucleoside inhibitor of HCV NS5B polymerase with binding affinity of 1.35 nM for genotype 1b.
-
Daclatasvir dihydroc...
A potent HCV NS5A inhibitor with EC50 of <50 pM against genotype 1 replicons.
-
Coblopasvir
Coblopasvir (KW136, KW-136) is a novel HCV NS5A inhibitor under development for treatment of HCV infection.
